Special Issue "Immunological Studies in Human Aging"

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Innate and Adaptive Immunity in Vaccination".

Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 207

Special Issue Editor

Dr. Anis Larbi
Guest Editor
1. Medical and Scientific Affairs, Beckman Coulter Life Sciences, 93420 Villepinte, France
2. Faculty of Medicine, University of Sherbrooke, Sherbrooke, QC J1H 5N4, Canada
Interests: immunological aging; flow cytometry

Special Issue Information

Dear Colleagues

We are pleased to invite you to submit your work to Vaccines in this Special Issue on immunological studies in human aging. Increased longevity in humans is multifactorial but significantly originates from sustaining immunity from early life to the end of life. Vaccination, antimicrobials, and other biomedical advances have improved the ability to fight against lethal infections, supporting a longer lifespan (years to life). Still, understanding how the immune system adapts to lifelong immunological challenges and to the overall physiological alterations has become important to support healthspan (life to years). This Special Issue aims to highlight novel studies, state-of-the-art reviews, and meta-analyses in the field of immunology in human aging. Responsiveness to vaccination, novel vaccination strategies, and the understanding of immunological processes in the context of human aging are topics of interest. New findings on the role of immune cell populations, soluble factors (cytokines, chemokines), and other soluble factors (extracellular vesicles) of the innate and adaptive immune system are welcomed. Contributions of technological advances (immuno-assays, data analysis) in this field will also be considered. Submissions related to the response to vaccination in older adults in the context of infectious diseases but also cancer are highly encouraged. We look forward to receiving your contributions

Dr. Anis Larbi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • immunology
  • aging
  • vaccination
  • immunosenescence
  • infectious diseases
  • technological advances

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop